In addition, relevant clinical studies have proved that leptin levels in human NAFLD are mostly normal or slightly elevated (Safar Zadeh et al., 2013; Polyzos et al., 2015), which also limit the application of leptin deficiency in mice. The gene discussed is LEP; the disease is metabolic dysfunction-associated steatotic liver disease.